We are live on ! Find out more
ABG

Ally Bridge Group Portfolio holdings

AUM $124M
1-Year Est. Return 249.88%
This Fund
S&P 500
This Quarter Est. Return
-6.59%
1 Year Est. Return
+249.88%
3 Year Est. Return
+942.29%
5 Year Est. Return
+671.08%
10 Year Est. Return
–
AUM
$151M
AUM Growth
+$41.7M
Cap. Flow
+$58.7M
Cap. Flow %
38.72%
Top 10 Hldgs %
53.82%
Holding
52
New
30
Increased
1
Reduced
6
Closed
13

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$15.1M
2
RARE icon
Ultragenyx Pharmaceutical
RARE
+$11.2M
3
SNY icon
Sanofi
SNY
+$10.2M
4
GSK icon
GSK
GSK
+$9.66M
5
AMRN
Amarin Corp
AMRN
+$8.53M

Top Sells

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$10.1M
2
COGT icon
Cogent Biosciences
COGT
+$8.96M
3
LNTH icon
Lantheus
LNTH
+$7.59M
4
GH icon
Guardant Health
GH
+$6.45M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$6.25M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
51
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-650,000
Closed -$6.25M
JNCE
52
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-550,000
Closed -$1.67M
1 2
3

Similar funds

MP
Marcho Partners London, United Kingdom $124M AUM 15.03% 1-Year Est. Return
EWP
E-Wealth Partners Minnetonka, Minnesota $124M AUM
WFA
WJ Financial Advisors Killingworth, Connecticut $124M AUM
VWM
Vigil Wealth Management Ponte Vedra Beach, Florida $124M AUM
EI
EDMP Inc Lutz, Florida $124M AUM 19.53% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $124M AUM
IFO
Intrepid Family Office Sarasota, Florida $124M AUM 37.91% 1-Year Est. Return
CRW
Clarity Retirement & Wealth New Bedford, Massachusetts $124M AUM

Ally Bridge Group's Q3 2022 Portfolio in Review

As of Q3 2022, Ally Bridge Group held 52 positions worth $151M, up 38% from $110M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Ally Bridge Group deployed $58.7M of net new capital in Q3 2022, opening 30 new positions and adding to 1 existing holding. Its largest new stake was Seagen Inc. Common Stock: 92,506 shares worth $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was argenx, an estimated $10.1M trimmed.

  • Ally Bridge Group's largest Q3 2022 buy was Seagen Inc. Common Stock: 92,506 shares worth $12.7M.
  • Ally Bridge Group added most to Syros Pharmaceuticals, Inc. Common Stock in Q3 2022, an estimated $4.32M increase.
  • Ally Bridge Group's biggest Q3 2022 reduction was argenx, cutting an estimated $10.1M.
  • Ally Bridge Group fully exited Lantheus in Q3 2022, selling an estimated $7.59M.
  • Ally Bridge Group's ten largest holdings make up 54% of its $151M portfolio in Q3 2022.
  • Ally Bridge Group opened 30 new positions and closed 13 in Q3 2022.
  • Ally Bridge Group's portfolio value rose 38% quarter-over-quarter to $151M.

Based on Ally Bridge Group's 13F filing for Q3 2022, filed 14 Nov 2022.